Transdermal Agomelatine Microemulsion Gel: Pyramidal Screening, Statistical Optimization and in Vivo Bioavailability

Overview

Journal Drug Deliv

Specialty Pharmacology

Date 2017 Aug 24

PMID 28831842

Citations 14

Authors

Mayada Said

Ibrahim Elsayed

Ahmed A Aboelwafa

Ahmed H Elshafeey

Affiliations

Soon will be listed here.

Abstract

Agomelatine is a new antidepressant having very low oral drug bioavailability less than 5% due to being liable to extensive hepatic 1st pass effect. This study aimed to deliver agomelatine by transdermal route through formulation and optimization of microemulsion gel. Pyramidal screening was performed to select the most suitable ingredients combinations and then, the design expert software was utilized to optimize the microemulsion formulations. The independent variables of the employed mixture design were the percentages of capryol 90 as an oily phase (X), Cremophor RH40 and Transcutol HP in a ratio of (1:2) as surfactant/cosurfactant mixture 'S' (X) and water (X). The dependent variables were globule size, optical clarity, cumulative amount permeated after 1 and 24 h, respectively (Q1 and Q) and enhancement ratio (ER). The optimized formula was composed of 5% oil, 45% S and 50% water. The optimized microemulsion formula was converted into carbopol-based gel to improve its retention on the skin. It enhanced the drug permeation through rat skin with an enhancement ratio of 37.30 when compared to the drug hydrogel. The optimum ME gel formula was found to have significantly higher C, AUC and AUC than that of the reference agomelatine hydrogel and oral solution. This could reveal the prosperity of the optimized microemulsion gel formula to augment the transdermal bioavailability of agomelatine.

Citing Articles

Characteristics of Hydrogels as a Coating for Microneedle Transdermal Delivery Systems with Agomelatine.

Wojtylko M, Nowicka A, Froelich A, Szybowicz M, Banaszek T, Tomczak D Molecules. 2025; 30(2).

PMID: 39860192 PMC: 11767663. DOI: 10.3390/molecules30020322.

Understanding Microemulsions and Nanoemulsions in (Trans)Dermal Delivery.

Musakhanian J, Osborne D AAPS PharmSciTech. 2025; 26(1):31.

PMID: 39794642 DOI: 10.1208/s12249-024-02997-2.

Ocular mucoadhesive and biodegradable spanlastics loaded cationic spongy insert for enhancing and sustaining the anti-inflammatory effect of prednisolone Na phosphate; Preparation, I-optimal optimization, and In-vivo evaluation.

Said M, Ali K, Alfadhel M, Afzal O, Aldosari B, Alsunbul M Int J Pharm X. 2024; 8:100293.

PMID: 39498272 PMC: 11533070. DOI: 10.1016/j.ijpx.2024.100293.

The influence of phototherapy on circadian melatonin and sleep regulation and potential benefits of these pathways in the management of vitiligo: a narrative review : Vitiligo, phototherapy, sleep and melatonin.

Xerfan E, Facina A, Tomimori J, Tufik S, Andersen M Arch Dermatol Res. 2024; 316(9):632.

PMID: 39305310 DOI: 10.1007/s00403-024-03363-9.

Design, optimization, and evaluation for a long-time-released transdermal microneedle delivery system containing estradiol.

Tang X, Qin H, Zhang X, Yang H, Yang J, Chen P Drug Deliv Transl Res. 2023; 14(6):1551-1566.

PMID: 38062287 DOI: 10.1007/s13346-023-01471-z.

References

Ustundag Okur N, Caglar E, Arpa M, Karasulu H . Preparation and evaluation of novel microemulsion-based hydrogels for dermal delivery of benzocaine. Pharm Dev Technol. 2016; 22(4):500-510. DOI: 10.3109/10837450.2015.1131716. View

Wang X, Xue M, Gu J, Fang X, Sha X . Transdermal microemulsion drug delivery system for impairing male reproductive toxicity and enhancing efficacy of Tripterygium Wilfordii Hook f. Fitoterapia. 2012; 83(4):690-8. DOI: 10.1016/j.fitote.2012.02.006. View

Azeem A, Khan Z, Aqil M, Ahmad F, Khar R, Talegaonkar S . Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm. 2008; 35(5):525-47. DOI: 10.1080/03639040802448646. View

Raza K, Singh B, Singal P, Wadhwa S, Katare O . Systematically optimized biocompatible isotretinoin-loaded solid lipid nanoparticles (SLNs) for topical treatment of acne. Colloids Surf B Biointerfaces. 2013; 105:67-74. DOI: 10.1016/j.colsurfb.2012.12.043. View

Magnusson B, Koskinen L . In vitro percutaneous penetration of topically applied capsaicin in relation to in vivo sensation responses. Int J Pharm. 2000; 195(1-2):55-62. DOI: 10.1016/s0378-5173(99)00337-3. View

Morsi N, Abdelbary G, Ahmed M . Silver sulfadiazine based cubosome hydrogels for topical treatment of burns: development and in vitro/in vivo characterization. Eur J Pharm Biopharm. 2013; 86(2):178-89. DOI: 10.1016/j.ejpb.2013.04.018. View

Liu Y, Chen L, Ji Y . Quantification and structural elucidation of potential impurities in agomelatine active pharmaceutical ingredient. J Pharm Biomed Anal. 2013; 81-82:193-201. DOI: 10.1016/j.jpba.2013.04.016. View

Kennedy S, Emsley R . Placebo-controlled trial of agomelatine in the treatment of major depressive disorder. Eur Neuropsychopharmacol. 2005; 16(2):93-100. DOI: 10.1016/j.euroneuro.2005.09.002. View

Loo H, Hale A, Dhaenen H . Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study. Int Clin Psychopharmacol. 2002; 17(5):239-47. DOI: 10.1097/00004850-200209000-00004. View

10.

McNeill S, Potts R, Francoeur M . Local enhanced topical delivery (LETD) of drugs: does it truly exist?. Pharm Res. 1992; 9(11):1422-7. DOI: 10.1023/a:1015854728278. View

11.

Abd Elbary A, Aboelwafa A, Al Sharabi I . Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design. AAPS PharmSciTech. 2011; 12(4):1454-64. PMC: 3225513. DOI: 10.1208/s12249-011-9708-9. View

12.

Balaguer-Fernandez C, Femenia-Font A, Muedra V, Merino V, Lopez-Castellano A . Combined strategies for enhancing the transdermal absorption of midazolam through human skin. J Pharm Pharmacol. 2010; 62(9):1096-102. DOI: 10.1111/j.2042-7158.2010.01142.x. View

13.

Nair A, Vyas H, Shah J, Kumar A . Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Drug Deliv. 2010; 18(1):19-25. DOI: 10.3109/10717544.2010.509361. View

14.

Xing M, Hui X, Zhong W, Pan N, Yaghmaie F, Maibach H . In vitro human topical bioactive drug transdermal absorption: estradiol. Cutan Ocul Toxicol. 2009; 28(4):171-5. DOI: 10.3109/15569520903097622. View

15.

Abdelrahman F, Elsayed I, Gad M, Badr A, Mohamed M . Investigating the cubosomal ability for transnasal brain targeting: In vitro optimization, ex vivo permeation and in vivo biodistribution. Int J Pharm. 2015; 490(1-2):281-91. DOI: 10.1016/j.ijpharm.2015.05.064. View

16.

Ban T . Pharmacotherapy of depression: a historical analysis. J Neural Transm (Vienna). 2001; 108(6):707-16. DOI: 10.1007/s007020170047. View

17.

Du T, Rao S, Wu L, Ye N, Liu Z, Hu H . An association study of the m6A genes with major depressive disorder in Chinese Han population. J Affect Disord. 2015; 183:279-86. DOI: 10.1016/j.jad.2015.05.025. View

18.

Andrews G, Poulton R, Skoog I . Lifetime risk of depression: restricted to a minority or waiting for most?. Br J Psychiatry. 2005; 187:495-6. DOI: 10.1192/bjp.187.6.495. View

19.

Essa E, Bonner M, Barry B . Electrically assisted skin delivery of liposomal estradiol; phospholipid as damage retardant. J Control Release. 2004; 95(3):535-46. DOI: 10.1016/j.jconrel.2003.12.015. View

20.

Khurana S, Jain N, Bedi P . Nanoemulsion based gel for transdermal delivery of meloxicam: physico-chemical, mechanistic investigation. Life Sci. 2013; 92(6-7):383-92. DOI: 10.1016/j.lfs.2013.01.005. View